Knopp Biosciences

Knopp Biosciences mainly focuses on diseases in the field of neurology, striving to provide breakthrough treatments for patients with inflammatory and neurological disorders to meet the current highly unmet medical needs. Currently, Knopp Biosciences has developed a discovery platform for small molecule mediators targeting epilepsy and neuropathic pain and has also developed an investigational compound for treating immune and blood disorders.